慢性心力衰竭治疗中脑钠肽水平检测的指导价值
2020-07-09李荣云
李荣云

[摘要] 目的 该次研究是为了分析脑钠肽水平的检测在治疗慢性心力衰竭中的指导意义。 方法 研究方便选取2017年6月—2019年6月两年时间里的86例患有慢性心力衰竭患者作为观察组,选取同一时间段健康的86名作为对照组,对于两组患者的血浆脑钠肽水平进行检测,并进行对比。 结果 发现观察组LVEF(41.34±10.45)%低于对照组(63.45±5.54)%(t=16.324,P=0.000);LVESD(48.23±7.56)mm高于对照组(29.45±8.21)mm,(t=14.8027,P=0.000);LVEDD(64.31±7.32)mm高于对照组(46.53±6.43)mm,(t=14.572,P=0.000);NT-proBNP(143.47±9.03)ng/L高于对照组(32.32±4.56)ng/L(t=43.570,P=0.000)。 结论 在治疗慢性心力衰竭中,检测脑钠肽水平具有非常重要的意义,可以给予临床医生更好的诊断标准,对于患者的病情有更准确的判断。
[关键词] 慢性心力衰竭;脑钠肽;指导价值
[中图分类号] R541.6 [文献标识码] A [文章编号] 1674-0742(2020)04(c)-0180-03
Guiding Value of Brain Natriuretic Peptide Levels in the Treatment of Chronic Heart Failure
LI Rong-yun
Department of Inner Medicine, Section One, Department of Emergency Medicine, Yiliang County Traditional Chinese Medicine Hospital, Kunming, Yunnan Province, 652100 China
[Abstract] Objective This study is to analyze the guiding significance of the detection of brain natriuretic peptide levels in the treatment of chronic heart failure. Methods From June 2017 to June 2019, 86 patients with chronic heart failure were convenient selected as the observation group, and 86 healthy people from the same time period were selected as the control group. Natriuretic peptide levels were measured and compared. Results It showed that LVEF (41.34±10.45)% in the observation group was lower than that in the control group (63.45±5.54)%(t=16.324, P=0.000); LVESD (48.23±7.56)mm was higher than the control group (29.45±8.21)mm( t=14.803, P=0.00); LVEDD (64.31±7.32)mm was higher than the control group (46.53±6.43)mm(t=14.572, P=0.000); NT-proBNP (143.47±9.03)ng/L was higher than the control group (32.32±4.56)ng/L(t=43.570, P=0.000). Conclusion In the treatment of chronic heart failure, the detection of brain natriuretic peptide level is of great significance. It can give clinicians better diagnostic criteria and have a more accurate judgment of the patient's condition.
[Key words] Chronic heart failure; Brain natriuretic peptide; Guiding value
隨着社会的不断发展,经济水平和医疗水平的不断提高,对于很多慢性疾病,有了越来越多的治疗手段,但是慢性疾病的发病率也在逐渐增加,近几年心脑血管疾病已经越来越威胁人们的生命。慢性心力衰竭对于人类是一个极大的威胁,发病率和致死率也越来越高,针对这种现象,医学界也在寻找更好的检测手段和治疗方法,争取可以做到早发现早治疗。目前,医学界对于慢性心力衰竭的报道也很多,脑钠肽是观察慢性心力衰竭的一个重要指标,而且所有的技术已经日渐成熟。一般患有慢性心力衰竭的患者,都是心脏功能不太完好,当心室感觉到压力和负荷增大的时候,就会释放出一种物质,这种物质和心钠肽具有相似的生物效应。正是由于这种物质的出现,对于慢性心力衰竭有了一个更好的诊断标准,对于治疗也有了一个新的出路。……
